我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

内皮祖细胞与支架术后再内皮化的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2011年第4期
页码:
535
栏目:
综述
出版日期:
2011-08-25

文章信息/Info

Title:
-
作者:
张鹏; 吴建祥; 冷冰 综述; 任雨笙 审校
第二军医大学第二附属医院心内科，上海 200003
Author(s):
-
关键词:
内皮祖细胞; 支架置入; 再狭窄; 再内皮化
Keywords:
-
分类号:
R543
DOI:
61-1268/R.20110504.0935.002
文献标识码:
A
摘要:
冠脉内支架置入术改变了冠心病的治疗格局，然而再狭窄和晚期支架内血栓形成是影响介入治疗疗效及临床应用的主要障碍。内皮祖细胞可以通过再内皮化作用有效地防止支架置入术后再狭窄与晚期血栓的发生，为冠心病的介入治疗提供广阔的应用前景。本文就近几年内皮祖细胞在再内皮化治疗方面的最新进展及存在的问题做一综述。
Abstract:
-

参考文献/References

[1]Kunz GA,Liang G,Cuculi F,et al.Circulating endothelial progenitor cells predict coronary artery disease severity[J].Am Heart J,2006,152(1):190-195.
[2]Sainz J,Al Haj Zen A,Caligiuri G,et al.Isolation of“side population”progenitor cells from healthy arteries of adult mice[J].Arterioscler Thromb Vasc Biol,2006,26(2):281-286.
[3]Bertolini F,Shaked Y,Mancuso P,et al.The multifaceted circulating endothelial cell in cancer: towards marker and target identification[J].Nat Rev Cancer,2006,6(11):835-845.
[4]Case J,Mead LE,Bessler WK,et al.Human CD34+AC133+VEGFR-2+cells are not endothelial progenitor cells but distinct,primitive hematopoietic progenitors[J].Exp Hematol,2007,35(7):1109-1118.
[5]Timmermans F,Van Hauwermeiren F,De Smedt M,et al.Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors[J].Arterioscler Thromb Vasc Biol,2007,27(7):1572-1579.
[6]Loomans CJ,Wan H,de Crom R,et al.Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression[J].Arterioscler Thromb Vasc Biol,2006,26(8):1760-1767.
[7]Fadini GP,Baesso I,Albiero M,et al.Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau[J].Atherosclerosis,2008,197(2):496-503.
[8]Povsic TJ,Goldschmidt-Clermont PJ.Endothelial progenitor cells: markers of vascular reparative capacity[J].Ther Adv Cardiovasc Dis,2008,2(3):199-213.
[9]Sprague EA.In vivo cardiovascular assays for drug discovery:evolution of the drug-eluting stent[J].Curr Opin Investig Drugs,2007,8(3):219-225.
[10]Mauri L,Hsieh WH,Massaro JM,et al.Stent thrombosis in randomized clinical trials of drug-eluting stents[J].N Engl J Med,2007,356(10):1020-1029.
[11]Inoue T,Node K.Molecular basis of restenosis and novel issues of drug-eluting stents[J].Circ J,2009,73(4):615-621.
[12]Ferri N,Granata A,Pirola C,et al.Fluvastatin synergistically improves the antiproliferative effect of everolimus on rat smooth muscle cells by altering p27Kip1/cyclin E expression[J].Mol Pharmacol,2008,74(1):144-153.
[13]陈婷婷,米卫东,王刚,等.粒细胞集落刺激因子动员内皮祖细胞治疗大鼠急性心肌梗死的疗效观察[J].心脏杂志,2009,21(4):467-470.
[14]Wu BJ,Midwinter RG,Cassano C,et al.Heme oxygenase-1 increases endothelial progenitor cells[J].Arterioscler Thromb Vasc Biol,2009,29(10):1537-1542.
[15]Laufs U,Custodis F,Bohm M.HMG-CoA reductase inhibitors in chronic heart failure: potential mechanisms of benefit and risk[J].Drugs,2006,66(2):145-154.
[16]鲍晓梅,吴春芳,路国平.阿托伐他汀对同型半胱氨酸所诱导内皮祖细胞功能损伤的保护作用[J].心脏杂志,2010,22(3):332-337.
[17]Blindt R, Vogt F,Astafieva I,et al.A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells[J].J Am Coll Cardiol,2006,47(9):1786-1795.

备注/Memo

备注/Memo:
收稿日期：2010-06-10.基金项目：上海市科学技术委员会科研计划项目资助(10411963900) 通讯作者：任雨笙，副主任医师，主要从事冠心病临床及基础研究Email:renyusheng@gmail.com 作者简介：张鹏，主治医师，硕士生Email:zhangpeng1996@gmail.com
更新日期/Last Update: 2011-06-02